After seven years of polycythemia vera masked by chronic iron deficiency, what mean corpuscular volume values are expected?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 10, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Expected MCV Levels After 7 Years of Iron-Deficient Polycythemia Vera

After seven years of polycythemia vera masked by chronic iron deficiency, expect a mean corpuscular volume well below 70 fL—typically in the range of 60-67 fL—representing severe microcytosis from prolonged iron depletion. 1, 2, 3

Understanding the Pathophysiology

The hematocrit in polycythemia vera reflects both red blood cell count (RBC) and mean corpuscular volume (MCV = HCT ÷ RBC). When chronic iron deficiency develops in PV patients, the elevated RBC count persists while MCV progressively falls, creating "masked" or "inapparent" polycythemia where the hematocrit appears deceptively normal despite true erythrocytosis. 1, 4

Degree of Microcytosis Expected

  • Severe microcytosis (MCV 60-67 fL) is characteristic of polycythemia vera with prolonged iron deficiency, as documented in patients with microcytic polycythemia where MCV values below 70 fL are common. 2, 3

  • The MCV rarely falls below 60 fL even with severe chronic iron deficiency, though values of 61 fL have been reported in extreme cases of anemia of chronic disease with microcytosis. 2

  • Patients with PV demonstrate significantly lower MCV ratios compared to other myeloproliferative neoplasm suspects when iron deficiency is present, with the correlation between RBC and hematocrit breaking down when microcytosis develops (R² = 0.87 only when microcytic individuals are excluded). 4

Associated Laboratory Findings

Beyond the low MCV, several other parameters help confirm this diagnosis:

  • Serum ferritin will be markedly reduced (typically <15-30 μg/L), confirming absent or severely depleted iron stores after years of consumption by the expanded red cell mass. 1, 5

  • Red cell distribution width (RDW) is typically elevated (>14-16%), distinguishing iron deficiency from thalassemia trait, which would show normal or minimally elevated RDW despite microcytosis. 1, 5, 6

  • Transferrin saturation falls below 16-20%, reflecting inadequate circulating iron for ongoing erythropoiesis despite the myeloproliferative drive. 5, 6

  • The RBC count remains elevated despite the microcytosis, which is the key distinguishing feature from simple iron deficiency anemia where RBC count would be reduced. 4, 3

Clinical Correlation with Symptoms

  • Pruritus severity correlates inversely with MCV in polycythemia vera patients, meaning that worsening microcytosis over seven years would be associated with more severe itching symptoms. 7

Diagnostic Pitfalls to Avoid

  • Do not assume microcytosis excludes polycythemia vera—the combination of elevated RBC count with MCV <70 fL should prompt consideration of PV with iron deficiency rather than thalassemia minor alone. 3

  • Do not rely on hematocrit alone for PV diagnosis when microcytosis is present, as the HCT may appear falsely normal or only mildly elevated despite true erythrocytosis (the RBC count more accurately reflects the hypercoagulable state). 4

  • Do not overlook combined deficiencies—iron deficiency can coexist with folate or B12 deficiency in PV patients, which may partially mask the degree of microcytosis while producing an elevated RDW. 1, 6

  • Ferritin may be falsely elevated above 12-15 μg/L if concurrent inflammation, malignancy, or hepatic disease is present, though values >100 μg/L make iron deficiency unlikely. 1, 6

Expected Response to Iron Repletion

  • Upon iron supplementation, the MCV will rise toward normal (80-100 fL) over 3-6 months as iron stores are replenished, while the RBC count and hematocrit will increase further, unmasking the true severity of the polycythemia. 5, 3

  • Hemoglobin should increase ≥10 g/L within 2 weeks of starting oral iron therapy if iron deficiency is contributing to the clinical picture. 5, 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Case report: severe microcytosis associated with the anemia of chronic disease.

Maryland medical journal (Baltimore, Md. : 1985), 1996

Guideline

Management of Microcytic Hypochromic Anemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Evaluation of Low MCV with Elevated RDW: Iron Deficiency vs. Idiopathic Erythrocytosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Pruritus Severity Correlates with Low Mean Corpuscular Volume in Polycythemia Vera

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What is the next step in managing a patient with persistent erythrocytosis (elevated Red Blood Cell (RBC) count), hyperhemoglobinemia (elevated Hemoglobin (HGB)), hyperhematocrit (elevated Hematocrit (HCT)), and increased Red Blood Cell (RBC) distribution width?
What is the diagnosis and treatment for a patient with elevated RBC count, hemoglobin, and hematocrit, along with microcytic anemia and low MCH and MCHC levels?
What is the lowest mean corpuscular volume (MCV) that can be seen in iron‑deficient (masked) polycythemia vera?
What is the management approach for a patient with microcytosis, indicated by an MCV (Mean Corpuscular Volume) result of 23.8?
What causes low MCV (Mean Corpuscular Volume), MCH (Mean Corpuscular Hemoglobin), MCHC (Mean Corpuscular Hemoglobin Concentration), high RDW (Red Cell Distribution Width), and slight traces of microcytosis and macrocytosis?
What are the changes in the diagnostic criteria for generalized anxiety disorder across the Diagnostic and Statistical Manual of Mental Disorders (DSM) versions III, III‑TR, IV, V, and V‑TR, and the International Classification of Diseases (ICD) versions X and XI?
How long should acetazolamide be continued in idiopathic intracranial hypertension before tapering, pending resolution of papilledema and normalization of visual fields?
What are the changes in the diagnosis of Anxiety Disorder Due to Another Medical Condition across the Diagnostic and Statistical Manual of Mental Disorders (DSM) versions III, III‑TR (Text Revision), IV, V, and V‑TR (Text Revision), and the International Classification of Diseases (ICD) versions X and XI?
A term (≈38‑week) newborn with absent deep‑tendon reflexes, tongue fasciculations and EMG denervation (consistent with spinal muscular atrophy type I) – what counseling should be given to the family regarding prognosis and treatment options?
What are the Philippine Society of Newborn Medicine guidelines for empiric antimicrobial therapy and overall management of suspected neonatal sepsis in neonates (≤28 days of life)?
What are the changes in the diagnosis of Other Specified Anxiety Disorder across the Diagnostic and Statistical Manual of Mental Disorders (DSM) versions III, III‑TR, IV, V, V‑TR and the International Classification of Diseases (ICD) versions X and XI?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.